This profile is for informational purposes only and is not medical advice. Consult a healthcare professional before use. See full terms.
Noopept
Noopept is a potent synthetic peptide-derived nootropic developed in Russia, often described as up to 1,000 times more potent than piracetam by weight. It enhances memory, learning, focus, and neuroprotection at very low doses.
Benefits
What is Noopept?
Noopept (N-phenylacetyl-L-prolylglycine ethyl ester, also known as GVS-111 or Omberacetam) is a synthetic nootropic peptide developed in the 1990s at the Russian Academy of Medical Sciences. While often grouped with racetams due to similar cognitive-enhancing effects, noopept is technically a dipeptide prodrug with a distinct mechanism of action.
Noopept is notable for its remarkable potency - effective doses are measured in milligrams rather than grams, making it roughly 1,000 times more potent than piracetam by weight. It is rapidly absorbed and crosses the blood-brain barrier efficiently, with effects often noticeable within 15–20 minutes of oral administration.
Research has demonstrated improvements in memory consolidation and retrieval, learning capacity, and attention. Noopept also exhibits significant neuroprotective properties, including antioxidant and anti-inflammatory effects that may help protect against age-related cognitive decline.
- BDNF and NGF upregulation: Noopept increases expression of Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF), proteins essential for neuronal growth, survival, and synaptic plasticity.
- Glutamate modulation: Enhances AMPA and NMDA receptor signalling, supporting long-term potentiation (LTP) - the cellular basis of learning and memory.
- Acetylcholine sensitisation: Increases sensitivity of acetylcholine receptors rather than directly increasing acetylcholine levels, supporting memory and attention.
- Antioxidant protection: Provides neuroprotection by reducing oxidative stress and inhibiting calcium overload in neurons, particularly under conditions of excitotoxicity.
- Anti-inflammatory effects: Reduces neuroinflammation by modulating inflammatory cytokines in the brain.
- Typical dose: 10–30 mg per day, divided into 2–3 doses
- Starting dose: 10 mg, taken sublingually or orally
- Sublingual administration: Placing powder under the tongue improves absorption and speeds onset
- Cycle: Often cycled - 56 days on, 4 days off (following the original Russian clinical protocol)
- Onset: Effects typically felt within 15–20 minutes
Due to its high potency, accurate dosing with a milligram scale is essential. Do not estimate doses with volumetric scoops.
- Side effects: Generally well-tolerated. Some users report headaches, irritability, or insomnia at higher doses.
- Toxicity: Low. Animal studies show a wide safety margin.
- Headaches: As with racetams, headaches may indicate choline depletion - stacking with Alpha-GPC or citicoline can help.
- Overstimulation: Some users report feeling overstimulated or anxious at doses above 30 mg.
- Legal status: Available over-the-counter in Russia. Sold as a research chemical or supplement in the US and UK - not FDA-approved.
Natural Sources & Forms
- Synthetic compound: Does not occur in nature - must be synthesised
- Supplement form: Available as capsules, powder, and sublingual tablets from nootropic vendors
- Brand name: Noopept (Russia) - sold as an over-the-counter cognitive enhancer
Research Studies
Frequently Asked Questions
Noopept is a potent synthetic peptide-derived nootropic developed in Russia, often described as up to 1,000 times more potent than piracetam by weight. It enhances memory, learning, focus, and neuroprotection at very low doses.
The key benefits of Noopept include: Anxiety & Calm, Cognitive Enhancement, Creativity, Focus, Longevity, Memory.
BDNF and NGF upregulation: Noopept increases expression of Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF), proteins essential for neuronal growth, survival, and synaptic plasticity. Glutamate modulation: Enhances AMPA and NMDA receptor signalling, supporting long-term potentiation (LTP) - the cellular basis of learning and memory. Acetylcholine sensitisation: Increases sensitivity of acetylcholine receptors rather than directly increasing acetylcholine levels, supporting memory and attention. Antioxidant protection: Provides neuroprotection by reducing oxidative stress and inhibiting calcium overload in neurons, particularly under conditions of excitotoxicity. Anti-inflammatory effects: Reduces neuroinflammation by modulating inflammatory cytokines in the brain.
Typical dose: 10–30 mg per day, divided into 2–3 doses Starting dose: 10 mg, taken sublingually or orally Sublingual administration: Placing powder under the tongue improves absorption and speeds onset Cycle: Often cycled - 56 days on, 4 days off (following the original Russian clinical protocol) Onset: Effects typically felt within 15–20 minutes Due to its high potency, accurate dosing with a milligram scale is essential. Do not estimate doses with volumetric scoops.
Side effects: Generally well-tolerated. Some users report headaches, irritability, or insomnia at higher doses. Toxicity: Low. Animal studies show a wide safety margin. Headaches: As with racetams, headaches may indicate choline depletion - stacking with Alpha-GPC or citicoline can help. Overstimulation: Some users report feeling overstimulated or anxious at doses above 30 mg. Legal status: Available over-the-counter in Russia. Sold as a research chemical or supplement in the US and UK - not FDA-approved.
Overall Rating
Log in to rate this nootropic.
Comments
Log in to leave a comment.
No comments yet. Be the first to share your experience!